Which local anesthetic is 1.5 times more potent than Lidocaine and biotransforms in plasma and liver, with reports of paresthesia and not used on children under 4 or for blocks?

Which local anesthetic is 1.5 times more potent than Lidocaine and biotransforms in plasma and liver, with reports of paresthesia and not used on children under 4 or for blocks?

• A. Articaine (Septocaine)
• B. Prilocaine
• C. Bupivacaine
• D. Mepivacaine

Answer: (A)

The key idea is that this local anesthetic has a unique metabolism and potency profile that matches the described properties. Articaine is about 1.5 times more potent than lidocaine, meaning you can achieve the same anesthesia with a smaller amount. What makes it stand out is its chemical structure that includes an ester group, allowing rapid hydrolysis in the plasma by esterases as well as metabolism in the liver for the amide portion. This dual metabolism contributes to its high potency combined with relatively quick clearance, which is why it’s often discussed in the context of strong efficacy with a favorable systemic safety profile. Paresthesia reports are a noted concern with articaine, particularly in cases involving nerve blocks, which is why this feature is highlighted in questions about its risks. Additionally, there are cautions in certain populations and indications—for instance, restrictions cited about use in very young children and for nerve blocks—reflecting safety considerations that accompany its use. In contrast, the other anesthetics listed are primarily amides metabolized mainly in the liver and do not combine the same level of potency with plasma ester hydrolysis. Their profiles don’t align with all the stated characteristics, so articaine best fits the described properties.

The key idea is that this local anesthetic has a unique metabolism and potency profile that matches the described properties. Articaine is about 1.5 times more potent than lidocaine, meaning you can achieve the same anesthesia with a smaller amount. What makes it stand out is its chemical structure that includes an ester group, allowing rapid hydrolysis in the plasma by esterases as well as metabolism in the liver for the amide portion. This dual metabolism contributes to its high potency combined with relatively quick clearance, which is why it’s often discussed in the context of strong efficacy with a favorable systemic safety profile.

Paresthesia reports are a noted concern with articaine, particularly in cases involving nerve blocks, which is why this feature is highlighted in questions about its risks. Additionally, there are cautions in certain populations and indications—for instance, restrictions cited about use in very young children and for nerve blocks—reflecting safety considerations that accompany its use.

In contrast, the other anesthetics listed are primarily amides metabolized mainly in the liver and do not combine the same level of potency with plasma ester hydrolysis. Their profiles don’t align with all the stated characteristics, so articaine best fits the described properties.